[1]
“Advancements in SGLT2 inhibitors: pharmacokinetics, pharmacodynamics, and clinical efficacy with a focus on pharmacogenomics”, Prospect. Pharm. Sci., vol. 23, no. 1, pp. 116–128, Mar. 2025, doi: 10.56782/pps.274.